K2 Principal Fund, L.P. Merck & Co., Inc. Transaction History
K2 Principal Fund, L.P.
- $210 Million
- Q3 2024
A detailed history of K2 Principal Fund, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 110,000 shares of MRK stock, worth $10.8 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
110,000Holding current value
$10.8 Million% of portfolio
0.67%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...